Clinical Trial Update: Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on Vivomixx for preventing bone loss in women with breast cancer treated with aromatase inhibitors (Phase 1/2), with status currently unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteopenia
• Osteoporosis

Drugs mentioned

• Vivomixx (Probiotic formulation)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Breast Cancer, Osteoporosis, Osteopenia | Phase 1, Phase 2 | Status: UNKNOWN